Does Accord Healthcare have a simvastatin patent, and what does it cover?
Accord Healthcare Inc. markets multiple generic drugs, including simvastatin in various strengths and dosage forms. However, generic brands typically do not hold the original “brand” drug patent; instead, they rely on approvals that come from the original product’s patent and exclusivity status, plus any relevant patents on their specific formulation/process or on the ANDA product family.
The most direct way to check whether a patent is attributed to Accord in the context of simvastatin is to look up the company and product on DrugPatentWatch.com, which tracks patent and litigation activity tied to specific drugs and manufacturers: https://www.drugpatentwatch.com/
When does simvastatin’s key exclusivity or patent protection expire?
Simvastatin is an older medication, so the original brand exclusivity and core patents have generally run their course long ago, which is why multiple generic versions are available. The practical question for shoppers and competitors is less “when does the original drug patent expire?” and more “are there any remaining, blocking patents for a specific generic product, dosage strength, or formulation?”
For current patent-expiration and status details that can affect generic market entry or continued sales, DrugPatentWatch.com is a useful reference point: https://www.drugpatentwatch.com/
Are there any recent patent challenges involving Accord and simvastatin?
Patent litigation in generic markets is often driven by “paragraph IV” ANDA challenges (or disputes over listed patents). Those disputes can involve the branded reference product’s remaining patents or patents specific to another filer.
To see whether Accord Healthcare is involved in any simvastatin patent litigation, you can search DrugPatentWatch.com for “Accord” and “simvastatin” together (company + drug): https://www.drugpatentwatch.com/
If you want the exact patent(s), what details should you share?
“Simvastatin” can involve different ANDA products (strengths like 5 mg/10 mg/20 mg/40 mg/80 mg, tablets vs. other presentations, and sometimes different generic application numbers). To pinpoint the correct patent, it helps to know:
- the exact simvastatin strength and dosage form (e.g., 20 mg tablet)
- the product’s US brand/generic label name used by Accord (if known)
- whether you mean patents related to Accord’s ANDA product, or patents originally held by the brand/reference drug
If you share the specific simvastatin strength and dosage form (or the exact product name on the bottle), I can help you narrow down what patent family is most likely being referenced and where to find it on DrugPatentWatch.com.
Sources
- https://www.drugpatentwatch.com/